This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| EUREC | |
|---|---|
| Name | EUREC |
| Formation | 1990s |
| Type | Consortium |
| Headquarters | Brussels |
| Region served | Europe |
EUREC EUREC is a European network of research ethics committees and ethics review organizations that facilitates coordination among institutional review boards, bioethics committees, and national regulators across the European Union, Council of Europe, and neighboring states. It serves as a platform for exchange among representatives from hospitals, universities, research institutes, and regulatory agencies to harmonize standards for clinical trials, biomedical research, and human-subjects protection. EUREC engages with stakeholders including research funders, patient organizations, and industry consortia to promote consistent review practices across the European Medicines Agency and national competent authorities.
EUREC functions as a collaborative umbrella linking representatives from bodies such as Comité Consultatif National d'Éthique, Federal Institute for Drugs and Medical Devices, Medical Research Council, Karolinska Institutet, and Paul Ehrlich Institute to address cross-border ethical issues raised by multicenter trials, genomics projects, and emerging technologies like CRISPR and AI. Member delegations often include professionals from Mayo Clinic, University College London, Heidelberg University, Aarhus University, and University of Barcelona who interact with regulators such as European Commission Directorate-General for Health and Food Safety and advisors from World Health Organization programs. The network convenes representatives from committees involved in landmark initiatives such as Horizon 2020, Horizon Europe, Innovative Medicines Initiative, European Research Council, and collaborative platforms with Bill & Melinda Gates Foundation-funded projects.
EUREC traces roots to meetings that followed high-profile regulatory and ethical controversies involving institutions like Tuskegee Institute-related debates, the fallout from the Declaration of Helsinki revisions, and regulatory reforms prompted by incidents considered by the European Court of Human Rights. Early contributors included members of National Bioethics Committees from France, Germany, United Kingdom, Italy, and Spain and stakeholders from agencies such as European Medicines Agency, Council of Europe, and Organisation for Economic Co-operation and Development. Over time, EUREC engaged with major research infrastructures like European Clinical Research Infrastructure Network, projects such as BBMRI-ERIC, and consortia linked to the Human Genome Project and International Committee of Medical Journal Editors. Its development paralleled legislation and guidance emanating from European Commission directives and interactions with actors like European Data Protection Supervisor and the Committee on Bioethics (DH-BIO).
Membership of EUREC comprises delegates from national research ethics committees, institutional review boards from universities such as University of Oxford, Sorbonne University, Utrecht University, and hospital ethics committees including Charité – Universitätsmedizin Berlin and Hospital Clínic de Barcelona. Observers commonly include representatives from European Medicines Agency, European Food Safety Authority, European Centre for Disease Prevention and Control, and funders like Wellcome Trust and Horizon Europe program officers. Affiliate members encompass professional organizations such as European Society of Human Genetics, European Society of Anaesthesiology, European Molecular Biology Laboratory, and patient groups affiliated with European Patients' Forum and Rare Diseases Europe. Secretariat functions are often hosted by academic centers or institutions like Vrije Universiteit Brussel or national health ministries.
EUREC undertakes activities including harmonization workshops, guideline drafting, capacity-building seminars, and advisory statements on topics such as informed consent, data sharing, biobanking, and artificial intelligence in research. It organizes symposia with partners like European Federation of Pharmaceutical Industries and Associations, European Public Health Association, European Society for Clinical Investigation, and collaborates with law-oriented bodies such as European Court of Justice-related legal scholars and institutes like Max Planck Institute for Innovation and Competition. EUREC contributes to policy dialogues relevant to multicenter trials overseen by agencies like National Institute for Health and Care Research and consults with ethics units at institutions including Institut Pasteur and Karolinska Institute.
Training offerings target ethics committee members drawn from universities such as Trinity College Dublin, University of Milan, and University of Helsinki and include modules on topics championed by organizations like Council of Europe and World Health Organization. Curricula often reference standards set by bodies like International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and draw on case studies from trials at centers such as Cochrane, Johns Hopkins University, Imperial College London, and Ghent University Hospital. Collaborative educational initiatives have linked EUREC with postgraduate programs at London School of Hygiene & Tropical Medicine, Ghent University, and summer schools run by European Network of Research Ethics Committees partners.
EUREC’s governance typically involves a steering committee comprising chairs of national ethics committees, academic leads from institutions like University of Copenhagen and University of Leiden, and liaisons from agencies including European Commission units and the European Medicines Agency. Funding sources are mixed: modest core support may come from participating institutions and national ministries such as Ministry of Health (France), supplemented by project grants from Horizon Europe, contracts with public health agencies like European Centre for Disease Prevention and Control, and sponsored workshops funded by philanthropic entities like Wellcome Trust and Gates Foundation. Formal secretariats sometimes receive administrative hosting by universities or research infrastructures such as BBMRI-ERIC.
EUREC has influenced harmonization of review practices across jurisdictions, informing guidance cited by European Medicines Agency and national competent authorities and shaping discourse in journals affiliated with European Journal of Human Genetics and BMJ. Critics point to challenges in representation—arguing that voices from smaller states, patient advocates associated with European Patients' Forum, and low-resource institutions like some Eastern European University Hospitals can be underrepresented—and to concerns about perceived industry influence when collaborating with organizations like European Federation of Pharmaceutical Industries and Associations. Debates have involved scholars from Oxford University, Harvard University, Yale University, and policy analysts at European Policy Centre and Bruegel over transparency, accountability, and the balance between research facilitation and protection of research subjects. Despite critiques, EUREC remains referenced in policy fora including European Commission consultations and workshops convened by World Health Organization regional offices.
Category:Research ethics committees